We made a preliminary exploration of the mechanisms involved and found that STS protects cancer cells against the chemotherapeutic agent ETO by reducing DNA damage, which is associated with a decrease in GAPDH levels and cell cycle arrest. This evidence concerns the gene GAPDH and cancer.